Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1775 of 2228 entries
View as:

Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT02254018 Org: User:
Start: 09/01/02 End: - Due: -

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 653048 BS H3PO4 Capsule Multiple Rising Doses in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02217631 Org: User:
Start: 10/31/09 End: - Due: -

An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options

Phase: N/A Priority: Normal
NCT ID: NCT04739150 Org: User:
Start: - End: - Due: -

Pharmacokinetic Study in Healthy Adult Volunteers to Assess the Interactions Between Steady-State Tipranavir and Atazanavir in the Presence of Ritonavir

Phase: N/A Priority: Normal
NCT ID: NCT02253836 Org: User:
Start: 01/31/05 End: - Due: -

4 Weeks Treatment of Type II Diabetic Patients With BI 44847

Phase: N/A Priority: Normal
NCT ID: NCT00558909 Org: User:
Start: 06/30/07 End: - Due: -

Relative Bioavailability of BI 671800 HEA in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02222233 Org: User:
Start: 01/31/10 End: - Due: -

Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Male and Female

Phase: N/A Priority: Normal
NCT ID: NCT02266472 Org: User:
Start: 11/30/14 End: 12/31/14 Due: 12/31/15

Influence of Pramipexole Extended Release on Medication Adherence in Parkinson´s Disease

Phase: N/A Priority: Normal
NCT ID: NCT01097421 Org: User:
Start: 03/31/10 End: - Due: -

Real World Glycemic Effectiveness of Linagliptin

Phase: N/A Priority: Normal
NCT ID: NCT03338803 Org: User:
Start: 11/21/17 End: 02/02/18 Due: 02/02/19

A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT03979807 Org: User:
Start: 06/10/19 End: 06/11/19 Due: 06/11/20

Effect of Meloxicam Tablets on Bleeding Time in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02183155 Org: User:
Start: 05/31/00 End: - Due: -

Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02262650 Org: User:
Start: 04/30/04 End: - Due: -

Investigation of Pharmacokinetic Drug-drug Interaction of BI 409306 and Donepezil in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02635750 Org: User:
Start: 01/15/16 End: 04/04/16 Due: 04/04/17

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 691751 in Healthy Asian Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02057835 Org: User:
Start: 03/31/14 End: 05/31/14 Due: 05/31/15

Safety of Dabigatran Etexilate in Blood Clot Prevention in Children

Phase: N/A Priority: Normal
NCT ID: NCT02197416 Org: User:
Start: 09/29/14 End: 11/19/19 Due: 11/19/20

Bioequivalence of a 2.5 mg Linagliptin / 850 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 850 mg Tablets in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02220647 Org: User:
Start: 01/31/10 End: - Due: -

Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02273492 Org: User:
Start: 08/31/99 End: - Due: -

This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills

Phase: N/A Priority: Normal
NCT ID: NCT03629054 Org: User:
Start: 08/27/18 End: 11/05/18 Due: 11/05/19

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01634139 Org: User:
Start: 07/31/12 End: 12/31/15 Due: 12/31/16

A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food

Phase: N/A Priority: Normal
NCT ID: NCT05347004 Org: User:
Start: 10/25/22 End: 12/28/22 Due: 12/28/23

A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate

Phase: N/A Priority: Normal
NCT ID: NCT00740051 Org: User:
Start: 08/31/08 End: - Due: -

Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02172807 Org: User:
Start: 12/31/00 End: - Due: -

Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171559 Org: User:
Start: 08/31/08 End: - Due: -

Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)

Phase: N/A Priority: Normal
NCT ID: NCT01895777 Org: User:
Start: 09/25/13 End: 11/14/19 Due: 11/14/20

BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02273388 Org: User:
Start: 11/04/05 End: 04/06/21 Due: 04/06/22